In the last trading session, 2.27 million shares of the HCW Biologics Inc (NASDAQ:HCWB) were traded, and its beta was 0.80. Most recently the company’s share price was $0.49, and it changed around $0.06 or 13.59% from the last close, which brings the market valuation of the company to $18.46M. HCWB currently trades at a discount to its 52-week high of $2.52, offering almost -414.29% off that amount. The share price’s 52-week low was $0.21, which indicates that the current value has risen by an impressive 57.14% since then. We note from HCW Biologics Inc’s average daily trading volume that its 10-day average is 36.32 million shares, with the 3-month average coming to 15.64 million.
HCW Biologics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended HCWB as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. HCW Biologics Inc is expected to report earnings per share of 0 for the current quarter.
HCW Biologics Inc (NASDAQ:HCWB) trade information
Instantly HCWB has showed a green trend with a performance of 13.59% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.0300 on recent trading dayincreased the stock’s daily price by 52.43%. The company’s shares are currently up 9.39% year-to-date, but still up 75.41% over the last five days. On the other hand, HCW Biologics Inc (NASDAQ:HCWB) is 19.02% up in the 30-day period. We can see from the shorts that 8092.0 shares have been sold at a short interest cover period of 0.28 day(s).
HCW Biologics Inc (HCWB) estimates and forecasts
The year-over-year growth rate is expected to be 222.75%, up from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 7M in revenue for the current quarter. Analysts predict that the company’s current quarter sales will jump, forecast at 428.70%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -34.57%. HCW Biologics Inc earnings are expected to increase by 18.57% in 2025, but the outlook is positive 8.29% per year for the next five years.
HCWB Dividends
HCW Biologics Inc’s next quarterly earnings report is expected to be released in March.
HCW Biologics Inc (NASDAQ:HCWB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 52.30% of HCW Biologics Inc shares, and 3.13% of them are in the hands of institutional investors. The stock currently has a share float of 6.56%. HCW Biologics Inc stock is held by 18.0 institutions, with AVANTAX PLANNING PARTNERS, INC. being the largest institutional investor. By 2024-06-30, it held 0.751% of the shares, which is about 0.28 million shares worth $0.18 million.
HIGHTOWER ADVISORS, LLC, with 0.4857% or 0.18 million shares worth $0.12 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Extended Market Index Fund and Bridgeway Funds Inc-Ultra Small Company Market Fund were the top two Mutual Funds as of Nov 30, 2024 . The former held 94.58 shares worth $46156.0, making up 0.25% of all outstanding shares. On the other hand, Bridgeway Funds Inc-Ultra Small Company Market Fund held roughly 84.7 shares worth around $41333.0, which represents about 0.22% of the total shares outstanding.
